Cargando…

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasia

Bronchopulmonary Dysplasia (BPD) is a disorder with a multifactorial etiology and highly variable clinical phenotype. Several traditional biomarkers have been identified, but due to the complex disease phenotype, these biomarkers have low predictive accuracy for BPD. In recent years, newer technolog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lal, Charitharth Vivek, Bhandari, Vineet, Ambalavanan, Namasivayam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862637/ https://www.ncbi.nlm.nih.gov/pubmed/30487069 http://dx.doi.org/10.1053/j.semperi.2018.09.004

Ejemplares similares

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

Duration of Noninvasive Respiratory Support and Risk for Bronchopulmonary Dysplasia or Death
por: Gentle, Samuel J, et al.
Publicado: (2022)

Bronchopulmonary dysplasia is associated with reduced oral nitrate reductase activity in extremely preterm infants
por: Gentle, Samuel J., et al.
Publicado: (2020)

Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and Proteomics
por: Capasso, Letizia, et al.
Publicado: (2019)

The Airway Microbiome at Birth
por: Lal, Charitharth Vivek, et al.
Publicado: (2016)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
por: Balena-Borneman, Jessica, et al.
Publicado: (2016)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

Serum Eotaxin-1 is Increased in Extremely Low Birth Infants with Bronchopulmonary Dysplasia or Death
por: Kandasamy, Jegen, et al.
Publicado: (2015)

Recent advances in understanding and management of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2020)

Can biomarkers be used to predict bronchopulmonary dysplasia?()
por: Bhandari, Vineet, et al.
Publicado: (2020)

The Airway Microbiome and Metabolome in Preterm Infants: Potential Biomarkers of Bronchopulmonary Dysplasia
por: Xu, Qi, et al.
Publicado: (2022)

Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia
por: Balany, Jherna, et al.
Publicado: (2015)

Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets
por: Bhandari, Vineet
Publicado: (2014)

Non-Invasive Ventilatory Strategies to Decrease Bronchopulmonary Dysplasia—Where Are We in 2021?
por: Dumpa, Vikramaditya, et al.
Publicado: (2021)

Mesenchymal stem cell bioenergetics and apoptosis are associated with risk for bronchopulmonary dysplasia in extremely low birth weight infants
por: Hazra, Snehashis, et al.
Publicado: (2022)

Supraphysiological Levels of Oxygen Exposure During the Neonatal Period Impairs Signaling Pathways Required for Learning and Memory
por: Ramani, Manimaran, et al.
Publicado: (2018)

The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
por: Xu, Yanping, et al.
Publicado: (2022)

How to decrease bronchopulmonary dysplasia in your neonatal intensive care unit today and “tomorrow”
por: Nelin, Leif D., et al.
Publicado: (2017)

Human Fetal Lungs Harbor a Microbiome Signature
por: Al Alam, Denise, et al.
Publicado: (2020)

miR34a: a master regulator in the pathogenesis of bronchopulmonary dysplasia
por: Das, Pragnya, et al.
Publicado: (2018)

Genetic Polymorphisms of Heme-oxygenase 1 (HO-1) may Impact on Acute Kidney Injury, Bronchopulmonary Dysplasia and Mortality in Premature Infants
por: Askenazi, David J, et al.
Publicado: (2015)

Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia
por: Sheth, Sudip, et al.
Publicado: (2019)

The Change of Cytokines and Gut Microbiome in Preterm Infants for Bronchopulmonary Dysplasia
por: Zhang, Zhenjie, et al.
Publicado: (2022)

Predicting BPD: Lessons Learned From the Airway Microbiome of Preterm Infants
por: Gentle, Samuel J., et al.
Publicado: (2020)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia
por: Baraldi, Eugenio, et al.
Publicado: (2016)

Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation
por: Wenger, Nancy M., et al.
Publicado: (2022)

Need for Supplemental Oxygen at Discharge in Infants with Bronchopulmonary Dysplasia Is Not Associated with Worse Neurodevelopmental Outcomes at 3 Years Corrected Age
por: Lodha, Abhay, et al.
Publicado: (2014)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

New insights into the natural history of bronchopulmonary dysplasia from proteomics and multiplexed immunohistochemistry
por: Dylag, Andrew M., et al.
Publicado: (2023)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_grj8gqlgfr12ei1u95q9ke23n6